US Drug Recall Register
Class III · Low risk Terminated Initiated Sep 3, 2021 (5 years ago)

Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications

What was recalled

Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21

Recalling firm
Meitheal Pharmaceuticals Inc
NDC code
71288-408-21
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0801-2021

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Glycopyrrolate recalls

See all